| __timestamp | Corcept Therapeutics Incorporated | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 18372000 | 18516000 |
| Thursday, January 1, 2015 | 15419000 | 34140000 |
| Friday, January 1, 2016 | 23844000 | 51872000 |
| Sunday, January 1, 2017 | 40376000 | 71772000 |
| Monday, January 1, 2018 | 75247000 | 97501000 |
| Tuesday, January 1, 2019 | 89017000 | 118590000 |
| Wednesday, January 1, 2020 | 114764000 | 169802000 |
| Friday, January 1, 2021 | 113864000 | 192507000 |
| Saturday, January 1, 2022 | 130991000 | 199563000 |
| Sunday, January 1, 2023 | 184353000 | 253598000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Corcept Therapeutics Incorporated and Xencor, Inc. have demonstrated significant growth in their R&D investments. Starting in 2014, both companies allocated around $18 million to R&D. By 2023, Corcept's R&D expenses surged by over 900%, reaching approximately $184 million, while Xencor's spending increased by nearly 1,300%, peaking at around $254 million. This upward trend highlights the companies' strategic focus on advancing their therapeutic pipelines. Notably, Xencor consistently outpaced Corcept in R&D spending, reflecting its aggressive approach to innovation. These investments underscore the importance of R&D in driving growth and maintaining a competitive edge in the biotech sector.
Analyzing R&D Budgets: Sanofi vs Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.